MENU
+Compare
CLGN
Stock ticker: NASDAQ
AS OF
Dec 18, 04:41 PM (EDT)
Price
$3.71
Change
+$0.07 (+1.92%)
Capitalization
41.69M

CLGN CollPlant Biotechnologies Ltd Forecast, Technical & Fundamental Analysis

a developer of medical devices

Industry Biotechnology
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for CLGN with price predictions
Dec 17, 2024

CLGN's Indicator enters downward trend

The Aroon Indicator for CLGN entered a downward trend on November 19, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 228 similar instances where the Aroon Indicator formed such a pattern. In of the 228 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CLGN as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CLGN turned negative on December 05, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

CLGN moved below its 50-day moving average on December 03, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLGN's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLGN advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CLGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.464) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). CLGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (64.103) is also within normal values, averaging (260.687).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CLGN is expected to report earnings to fall 27.63% to -27 cents per share on April 02

CollPlant Biotechnologies Ltd CLGN Stock Earnings Reports
Q4'24
Est.
$-0.28
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.02
Q4'23
Missed
by $0.29
The last earnings report on November 27 showed earnings per share of -37 cents, missing the estimate of -28 cents. With 7.49K shares outstanding, the current market capitalization sits at 41.69M.
A.I. Advisor
published General Information

General Information

a developer of medical devices

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4 Oppenheimer Street
Phone
+972 732325600
Employees
73
Web
https://www.collplant.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNCE1.580.19
+13.67%
VINCE HOLDING Corp
DMLP32.55-0.19
-0.58%
Dorchester Minerals LP
AFL102.75-1.06
-1.02%
Aflac
MDU18.55-0.30
-1.59%
MDU Resources Group
RYAM7.66-0.29
-3.65%
Rayonier Advanced Materials

CLGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with CMVLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
+0.45%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
-1.45%
VOR - CLGN
25%
Poorly correlated
-4.28%
CVAC - CLGN
24%
Poorly correlated
-4.84%
AVXL - CLGN
24%
Poorly correlated
+0.33%
More